EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Approach to the Patient: Reninoma

Annabelle G Hayes iD, Michael Stowasser iD, Mahesh M Umapathysivam iD, Henrik Falhammar iD, David J Torpy iD

The Journal of Clinical Endocrinology & Metabolism · 18.01.2024 · 109 (2) · e809-e816

DOI: 10.1210/clinem/dgad516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 30.08.2023. Verfasst von Annabelle G Hayes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia 5000, Australia. Hauptthemen laut MEDLINE: Kidney Neoplasms, Hyperaldosteronism, Adenoma, Hypertension. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A reninoma is a functional tumor of afferent arteriolar juxtaglomerular cells that secretes the enzyme renin, leading to hyperactivation of the renin-angiotensin-aldosterone system. Reninoma is a potentially curable cause of pathological secondary hyperaldosteronism that results in often severe hypertension and hypokalemia. The lack of suppression of plasma renin contrasts sharply with the much more common primary aldosteronism, but diagnosis is often prompted by screening for that condition. The major differential diagnosis of reninoma is renovascular hypertension. Fewer than 200 cases of reninoma have been described. Reninomas have been reported across a broad demographic but have a 2:1 predilection for women, often of childbearing age. Aldosterone receptor blockade, angiotensin-converting enzyme inhibitors, or angiotensin receptor blockers offer effective medical management but are contraindicated in pregnancy, so surgical curative resection is ideal. The current optimal imaging and biochemical workup of reninoma and management approach (ideally, tumor excision with subtotal renal resection) are described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsHyperaldosteronismAdenomaHypertensionHumansFemaleReninKidneyRenin-Angiotensin SystemAldosterone

Stichwörter der Autor:innen

juxtaglomerular cell tumorreninreninomasecondary aldosteronismsecondary hypertension

Substanzen

ReninAldosterone

Autor:innen und Institutionen

  • Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia 5000, Australia.
  • Faculty of Medicine, University of Adelaide, Adelaide, South Autralia 5000, Australia.
  • Endocrine Hypertension Research Centre, University of Queensland Diamantina Institute, Brisbane, Queensland 4102, Australia.
  • Endocrine Hypertension Unit, Greenslopes and Princess Alexandra Hospitals, Brisbane, Queensland 4102, Australia.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-171 76, Sweden.
  • Department of Endocrinology, Karolinska University Hospital, Stockholm SE-171 76, Sweden.

ORCID-Profile: Annabelle G Hayes, Michael Stowasser, Mahesh M Umapathysivam, Henrik Falhammar, David J Torpy

Zitieren

APA

Hayes, A. G., Stowasser, M., Umapathysivam, M. M., Falhammar, H., & Torpy, D. J. (2024). Approach to the Patient: Reninoma. The Journal of Clinical Endocrinology & Metabolism, 109(2), e809-e816. https://doi.org/10.1210/clinem/dgad516

Vancouver

Hayes AG, Stowasser M, Umapathysivam MM, Falhammar H, Torpy DJ. Approach to the Patient: Reninoma. The Journal of Clinical Endocrinology & Metabolism. 2024;109(2):e809-e816. doi:10.1210/clinem/dgad516

BibTeX
@article{Hayes2024,
  author = {Hayes, Annabelle G and Stowasser, Michael and Umapathysivam, Mahesh M and Falhammar, Henrik and Torpy, David J},
  title = {Approach to the Patient: Reninoma},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  volume = {109},
  number = {2},
  pages = {e809--e816},
  doi = {10.1210/clinem/dgad516}
}
Kostenlos starten →